Form Type: 4

SEC EDGAR Link
Accession Number:0001725160-21-000176
Date:2021-08-02
Issuer: ZENTALIS PHARMACEUTICALS, INC. (ZNTL)
Original Submission Date:

Reporting Person:

SUN ANTHONY Y
C/O ZENTALIS PHARMACEUTICALS, INC.
530 SEVENTH AVENUE, SUITE 2201 NEW YORK, NY 10018

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-08-02 S 6,900 d $50.01 1,344,030 direct
COMMON STOCK 2021-08-02 S 9,182 d $51.30 1,334,848 direct
COMMON STOCK 2021-08-02 S 2,006 d $52.29 1,332,842 direct
COMMON STOCK 2021-08-02 S 927 d $53.14 1,331,915 direct
COMMON STOCK 2021-08-03 S 2,513 d $50.01 1,329,402 direct
COMMON STOCK 2021-08-03 S 4,659 d $50.70 1,324,743 direct
COMMON STOCK 2021-08-03 S 607 d $51.36 1,324,136 direct
COMMON STOCK 2021-08-02 0 $0.00 974,302 indirect
COMMON STOCK 2021-08-02 0 $0.00 213,600 indirect f9
COMMON STOCK 2021-08-02 0 $0.00 228,650 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the sale reported in the form 4 was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on september 22, 2020.
f2 the price reported is a weighted average price. the shares were sold in multiple transactions at per share prices ranging from $49.57 to $50.50. the reporting person undertakes to provide upon request to the sec staff, the issuer, or any stockholder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f3 the price reported is a weighted average price. the shares were sold in multiple transactions at per share prices ranging from $50.73 to $51.67. the reporting person undertakes to provide upon request to the sec staff, the issuer, or any stockholder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f4 the price reported is a weighted average price. the shares were sold in multiple transactions at per share prices ranging from $51.75 to $52.72. the reporting person undertakes to provide upon request to the sec staff, the issuer, or any stockholder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f5 the price reported is a weighted average price. the shares were sold in multiple transactions at per share prices ranging from $52.78 to $53.37. the reporting person undertakes to provide upon request to the sec staff, the issuer, or any stockholder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f6 the price reported is a weighted average price. the shares were sold in multiple transactions at per share prices ranging from $49.30 to $50.28. the reporting person undertakes to provide upon request to the sec staff, the issuer, or any stockholder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f7 the price reported is a weighted average price. the shares were sold in multiple transactions at per share prices ranging from $50.30 to $51.25. the reporting person undertakes to provide upon request to the sec staff, the issuer, or any stockholder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f8 the price reported is a weighted average price. the shares were sold in multiple transactions at per share prices ranging from $51.31 to $51.39. the reporting person undertakes to provide upon request to the sec staff, the issuer, or any stockholder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f9 represents shares nominally held by hao bao zi trust llc on behalf of the hao bao zi trust (the "trust"), the sole member of hao bao zi trust llc. the reporting person's spouse is the investment adviser with sole power to make investment decisions regarding the securities held by the trust. the reporting person disclaims beneficial ownership of the securities held by hao bao zi trust llc except to the extent of his pecuniary interest therein, if any.
WhaleWisdom Logo

Elevate your investments